Testing effectiveness (Phase 2)Study completedNCT00080106
What this trial is testing
Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114